Celltex News
Celltex has submitted Emergency Expanded Access Clinical Study for Subjects with Coronavirus 2019 (COVID-19) using multiple dose Infusions of Autologous Adipose-Tissue Derived Mesenchymal Stem Cells (ADMSCs)
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies.
On March 21st, 2020, Celltex submitted an emergency expanded access clinical study to the United States Food and Drug Administration (FDA) that would allow patients with COVID-19 to receive infusions of autologous Adipose-tissue derived Mesenchymal Stem Cells (AdMSCs) in the US. The team working on this expanded access protocol for COVID-19 consists of Dr. Jane Young, Chief Scientific Officer- Celltex and Dr. Derek W. Guillory, Principal Investigator-Root Causes Medicine San Antonio.
If you currently have your MSCs banked at Celltex and are wondering what options are available to you, please contact the Client Services team today by completing the form on our Request a Consultation page, by calling (713) 590-1000 or sending an email to info@celltexbank.com. If you are not a client but would like to bank your MSCs, please complete our online client assessment and a Client Services Coordinator will contact you.
More Recent News
From Totipotent to Unipotent: Understanding Stem Cell Types and Differentiation Potential
Although stem cell therapy’s future applications and potential are still being investigated, stem cells have revolutionized the landscape of medicine, offering a promising therapy option for many conditions and diseases.
However, if you’re interested in receiving stem cell therapy in the future, be aware that not all stem cells are the same. It’s important to understand the differences between various types of stem cells and which ones are utilized in regenerative medicine.
Read MoreWhat Is Stem Cell Banking?
Thanks to advancements in stem cell research, particularly the recognition of the regenerative properties of Mesenchymal Stem Cells (MSCs), Adult Stem Cell Banking has become a versatile and promising avenue for accessing personalized healthcare and future therapeutic interventions.
In this article, we describe the Stem Cell Banking process in detail and explain how it may greatly increase the potential for positive results when therapeutic application is necessary.
Read More